Quantum Pharmaceutical, a UK manufacturer and supplier of unlicensed medicines and specials provider, has appointed Mark Dodd as its new business development manager.
Dodd has over 25 years’ experience in sales and business development within the pharmaceutical and private healthcare sectors, specialising in market access programmes.
He has an extensive knowledge of the NHS, having worked with prescribers and medicine management specialists across primary and secondary care.
At Quantum, Dodd will focus specifically on the development of Biodose, the leading edge medicines delivery system which allows solid and liquid medicines to be presented to the patient in the same container.
